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Background: The threshold of intraoperative urine output under which the risk of acute 
kidney injury (AKI) increases is unclear. The aim of this large-scale retrospective 
cohort study was to investigate the relationship between intraoperative urine output 
during major abdominal surgery and the development of postoperative AKI, as well as 
to identify an optimal threshold for predicting the differential risk of AKI. 
Methods: The authors retrospectively collected perioperative data for 3,560 patients 
undergoing major abdominal surgery (liver, colorectal, gastric, pancreatic or 
oesophageal resection) at Kyoto University Hospital. We evaluated the relationship 
between intraoperative urine output and the development of postoperative AKI as 
defined by recent guidelines. Logistic regression analysis was performed to adjust for 
patient and operative variables, and the minimum P-value approach was used to 
determine the threshold of intraoperative urine output that independently altered the risk 
of AKI. 
Results: The overall incidence of AKI in the study population was 6.3%. Using the 




there was an increased risk of AKI (adjusted odds ratio: 2.65; 95% confidence interval: 
1.77–3.97; P < 0.001). The addition of oliguria under 0.3 mL kg-1 h-1 to a model with 
conventional risk factors significantly improved risk stratification for AKI (net 
reclassification improvement: 0.159; 95% confidence interval: 0.049–0.270; P = 0.005). 
Conclusions: Among patients undergoing major abdominal surgery, intraoperative 
oliguria under 0.3 mL kg-1 h-1 was significantly associated with increased risk of 
postoperative AKI. 
 






Oliguria is widely viewed as an early marker of decreased kidney perfusion and 
impending acute kidney injury (AKI). The use of urine output (UO) to guide fluid 
therapy is often recommended by textbooks and guidelines1–3 and is the standard 
practice in perioperative or critical care settings.4 5 
Although oliguria is usually defined as UO less than 0.5 mL kg-1 h-1 in medical and 
surgical practice,1 2 this threshold of UO is not supported by clinical evidence. The most 
recent update of the Surviving Sepsis Campaign guidelines does not mention the target 
value of UO;3 this is in contrast to the previous version which recommended that the 
goals of initial resuscitation should include UO of ≥0.5 mL kg-1 h-1.6 Although serum 
creatinine (SCr) roughly represents the glomerular filtration rate,7 UO is influenced by 
many factors including haemodynamics, sympathetic tone and aldosterone and 
anti-diuretic hormone levels. Therefore, thresholds of clinically significant oliguria, 
indicating renal hypoperfusion or impending AKI, may vary depending on clinical 
settings or patient conditions. 
Fluid replacement targeting a higher UO tends to lead to increased fluid loading, which 




overloading markedly increases postoperative morbidity and length of hospital stay.8–11 
Conversely, allowing a lower UO may cause renal hypoperfusion and associated kidney 
damage. Therefore, identifying the optimal threshold for clinically significant oliguria 
may help optimise fluid management. However, to our knowledge, no study has 
attempted to identify an optimal threshold of intraoperative UO in surgical patients 
associated with increased risk of postoperative AKI. 
The authors hypothesised that there is a threshold of intraoperative UO under which the 
risk of postoperative AKI increases. The aims of this large-scale retrospective study 
were 1) to investigate the relationship between intraoperative UO during major 
abdominal surgery and the development of postoperative AKI and 2) to identify an 






Study design, Setting and Population 
This single-centre retrospective cohort study was conducted in Kyoto University 
Hospital, which is a teaching hospital with 1,121 beds in Japan. The institutional review 
board approved the study protocol (approval number: R0672, 26 July, 2016) and waived 
the requirement for informed consent. 
We included patients aged 18 years or older who underwent major abdominal surgery 
under general anaesthesia at Kyoto University Hospital from March 2008 to April 2015, 
i.e., from the institution of electronic database of surgical patients at our centre to the 
conception of this study. Major abdominal surgery included liver, colorectal, gastric, 
pancreatic or oesophageal resection by either laparotomy or laparoscopic approach. For 
patients who had more than one surgery that met the inclusion criteria during the study 
period, only the index case was included. Exclusion criteria were concurrent cardiac or 
urological procedures and patients with end-stage renal disease (i.e., estimated 




validated in Japan,12 or receipt of haemodialysis). In addition, patients who received 
diuretics (furosemide, human atrial natriuretic peptide or mannitol) intraoperatively 
were also excluded to eliminate the confounding of intraoperative use of diuretics. 
 
Data collection 
Data on study participants were collected from the electronic database and the 
electronic medical record system. To prevent variability in data collection, we collected 
data according to uniform criteria, especially regarding definitions of the medical 
conditions. Definitions of variables are listed in Supplementary Table S1. Procedure 
names recorded in the electronic database were used to identify and group major 
abdominal surgeries. The type of surgery was categorised into six groups (liver, 
colorectal, gastric, pancreatic, oesophageal and complex) and also divided into 
laparoscopic/non-laparoscopic surgery. 'Complex' means concomitant resection of two 
or more organs listed above. For each case, we calculated average intraoperative UO per 
hour based on body weight by dividing total intraoperative UO by duration of operating 






The primary outcome was AKI as determined by change in SCr according to the Kidney 
Disease: Improving Global Outcomes (KDIGO) definition13 (increase in SCr of ≥26.5 
µmol L-1 within 48 h or ≥1.5 times baseline within 7 days after surgery). The most 
recent SCr measured before the surgery was used as the baseline value. 
 
Statistical analyses 
The analyses on the relationship between intraoperative UO and AKI were planned 
prior to data evaluation. We examined the unadjusted relationship between 
intraoperative UO and the risk of AKI using cubic spline function to identify any 
inflection point that could be used to dichotomise intraoperative UO into categories in a 
clinically meaningful way. If we observed an area of inflation, the optimal threshold for 
intraoperative UO was determined using the minimum P-value approach. This approach 
evaluated every possible threshold of intraoperative UO at intervals of 0.1 mL kg-1 h-1 in 




the smallest statistically significant P-value was selected as the optimal threshold to 
dichotomise intraoperative UO. In the multivariable model, AKI risk index14 was used 
to adjust for preoperative risk of AKI. This is a previously developed and validated risk 
index for predicting postoperative AKI in patients undergoing general surgery and 
includes age, gender, emergency surgery, intra-peritoneal surgery, diabetes mellitus, 
active congestive heart failure, ascites, hypertension and preoperative renal 
insufficiency. In addition, type of surgery, intraoperative blood loss (per kg body 
weight) and intraoperative continuous infusion of vasopressors were included in the 
model to adjust for type and invasiveness of surgery. The linearity of the association 
between intraoperative blood loss and the log-odds of AKI was assessed using cubic 
spline function and categorised if significant non-linearity (P <0.05) was found. 
Multicollinearity among variables was assessed by the variance inflation factor with a 
reference value of 10. Discrimination and calibration of the multivariable model was 
assessed based on the c-index and the Hosmer–Lemeshow goodness-of-fit test, 
respectively. We assessed whether the addition of intraoperative UO to the model that 




for AKI by calculating the category-free net reclassification improvement (NRI) and the 
integrated discrimination improvement (IDI). 
We expected that the relationship between intraoperative UO and AKI would vary 
depending on patient or operative characteristics. Accordingly, we assessed this 
potential heterogeneity by subgroup analyses. We used the same model in the following 
subgroups: (1) AKI risk index (class 1/class 2/class 3–5); (2) type of surgery 
(liver/colorectal/gastric/others); (3) blood loss (<10 mL kg-1/≥10 mL kg-1) and (4) 
laparoscopic surgery (yes/no). We calculated the adjusted odds ratio for AKI in each 
subgroup and then, tested the interaction between subgroups and intraoperative UO. 
We assessed the robustness of our findings using sensitivity analyses. Sensitivity 
models were constructed as logistic regression identical to the primary model above, 
except (1) with the primary outcome AKI redefined on the basis of SCr concentrations 
only up to 2 days postoperatively; (2) using severe AKI (stage 2–3 AKI according to 
KDIGO guidelines) as the outcome; (3) adjusting for the duration of the surgery; (4) 
using ideal body weight (determined with the body mass index method15 16) to calculate 




infusion; (6) excluding patients who received diuretics preoperatively and (7) excluding 
emergency surgeries. 
The sample size was determined by including all eligible cases in the electronic 
database to maximise the power. Previous studies have suggested that at least 8–10 
events per variable are required for reliable multivariable logistic regression analysis.17 
18 We assumed approximately 500 eligible surgeries per year and predicted the 
prevalence of AKI to be 6% on the basis of published reports.19–21 So we estimated that 
we can conduct multivariable logistic regression with approximately 24 variables using 
our dataset. As for missing values, we planned to conduct a complete case analysis if 
the missing values were below 5% because such an analysis might have been feasible in 
that case.22 
All statistical tests were two tailed and a P-value of <0.05 was considered to be 
statistically significant. All statistical analyses were performed using the statistical 





Fig. 1 shows the flow diagram of this study. A total of 3,804 index major abdominal 
surgeries were identified in the electronic database spanning an approximately 7-year 
period from March 2008 to April 2015. After excluding patients with end-stage renal 
disease (n = 39) and those who received diuretics during the surgery (n = 201), 3,564 
patients met the inclusion criteria of this study. Among these patients, data on 
intraoperative UO were missing in three patients and data on intraoperative blood loss 
were missing in one patient. Overall, cases with any missing predictor were 4 in number 
(0.1%); therefore, we conducted complete case analysis leaving 3,560 patients for 
further evaluation. 
Study participants were aged 19–94 years, and 38.7% were women. The most common 
surgeries were liver resection (31.9%) and colorectal resection (29.6%). The median 
intraoperative UO for the study population was 0.81 mL kg-1 h-1. 
Of the 3,560 patients included in this study, 226 patients (6.3%; 95% CI: 5.6%–7.2%) 
developed AKI; patients with AKI had a significant increase in in-hospital mortality 




0.001). Table 1 shows patient characteristics and operative variables stratified by the 
AKI status. Patients who developed AKI had higher AKI risk index, had more blood 
loss and were more likely to receive intraoperative vasopressor infusion. Intraoperative 
UO in patients with AKI was lower than in those without. The cubic spline relating 
intraoperative UO to AKI was negatively sloped with inflection point at approximately 
0.3–0.4 mL kg-1 h-1 after which the probability of AKI almost plateaued (Fig. 2). Based 
on this result, the range from 0.1 to 1.0 mL kg-1 h-1 was selected for determining the 
optimal threshold for intraoperative UO and possible thresholds at intervals of 0.1 mL 
kg-1 h-1 were considered. Using the minimum P-value approach, multivariable analysis 
demonstrated that the ideal threshold of intraoperative UO was 0.3 mL kg-1 h-1 
(Supplementary Table S2). An intraoperative UO of <0.3 mL kg-1 h-1 occurred in 11.3% 
of patients. These patients had a higher AKI risk index, were more likely to undergo 
laparoscopic surgery and had less blood loss and lower net fluid balance 
(Supplementary Table S3). The incidences of AKI were 10.2% and 5.9% in patients 
with intraoperative UO of <0.3 and ≥0.3 mL kg-1 h-1, respectively. 




independently associated with the development of AKI (adjusted odds ratio: 2.65; 95% 
CI: 1.77–3.97; P < 0.001; Table 2). In this multivariable analysis, intraoperative blood 
loss was categorised into three groups (<10 mL kg-1, 10–<20 mL kg-1 and ≥20 mL kg-1) 
based on the result of cubic spline function analysis (Supplementary Fig. S1). Each 
variable included in the models demonstrated a variance inflation factor of <10, 
suggesting no multicollinearity. Both multivariable models without/with intraoperative 
UO demonstrated good discrimination [c-indices: 0.782 (95% CI: 0.751–0.813) and 
0.791 (95% CI: 0.760–0.821), respectively] and calibration (P-values for Hosmer–
Lemeshow goodness-of-fit test: 0.414 and 0.164, respectively). 
We found that the category-free NRI for the addition of intraoperative UO to the model 
that only included AKI risk index and operative variables was 0.159 (95% CI: 0.049–
0.270; P=0.005; Table 3). The IDI for the addition of intraoperative UO was 0.009 
(95% CI: 0.003–0.015; P=0.003). 
Because oliguria is usually defined as diuresis of less than 0.5 mL kg-1 h-1, we carried 
out additional analysis calculating the risk of AKI associated with milder oliguria 




intraoperative UO of <0.3 mL kg-1 h-1. There was not a statistically significant risk of 
AKI for intraoperative UO of 0.3–<0.5 mL kg-1 h-1 (adjusted odds ratio: 1.37; 95% CI: 
0.88–2.13; P = 0.160).  
Subgroup analyses based on the AKI risk index, type of surgery, blood loss and 
laparoscopic surgery yielded wider confidence intervals but did not substantially affect 
the point estimates for the impact of intraoperative UO of <0.3 mL kg-1 h-1 on AKI, 
suggesting that there was no interaction between these variables and intraoperative UO 
(Fig. 3). The relationship between intraoperative UO and AKI was qualitatively 






In this cohort study of 3,560 patients undergoing major abdominal surgery, we found 
that intraoperative UO of <0.3 mL kg-1 h-1 was independently associated with 
postoperative AKI. 11.3% of patients had an intraoperative UO of <0.3 mL kg-1 h-1, and 
the risk for AKI increased by approximately 2.7 times in these patients. NRI analysis 
demonstrated that intraoperative UO of <0.3 mL kg-1 h-1 significantly improved risk 
stratification for AKI compared with assessment limited to AKI risk index and 
operative variables. In contrast, intraoperative UO of 0.3–<0.5 mL kg-1 h-1 was not 
significantly associated with increased risk of AKI. 
Previous studies in perioperative settings failed to demonstrate significant association 
between intraoperative UO and AKI,23 24 and recent review suggested that intraoperative 
UO is not related to perioperative renal function.25 Alpert et al.23 reported that there was 
no significant correlation between intraoperative UO and postoperative renal function in 
patients undergoing abdominal aortic reconstruction. However, this study included only 
137 patients and therefore, was too underpowered to conclude the predictive value of 




undergoing abdominal aortic reconstruction, which limits generalisability. A large 
retrospective study that evaluated risk factors for AKI in non-cardiac surgical patients 
did not find intraoperative oliguria to be predictive of postoperative AKI.24 However, 
this study examined only a single threshold of low UO (<0.5 mL kg-1 h-1). This 
approach may miss the association between intraoperative UO and AKI even if patients 
with severe oliguria had a high incidence of AKI due to dilution by the larger patient 
population with UO immediately below the predetermined threshold with few AKI 
events. Furthermore, diuretics were used intraoperatively for some of the participants, 
which may have biased the results. 
Our study was designed to overcome some of the limitations of these studies. First, it 
involved a large cohort of patients undergoing a broad spectrum of intra-abdominal 
procedures, which enabled a robust evaluation of relationships between exposure and 
outcome with sufficient statistical power. Second, we excluded patients receiving 
diuretics intraoperatively, which enabled us to analyse the relationship between 
intraoperative UO and AKI eliminating the effect of diuretics. Third, rather than 




threshold of UO. This approach allowed us to better relate the severity of intraoperative 
UO and AKI. To our knowledge, this is the first study to attempt to identify an optimal 
threshold of intraoperative UO associated with a differential risk of AKI. 
In view of the results of recent randomised trials that perioperative fluid overloading is 
associated with poor postoperative outcomes,8–11 intraoperative fluid restriction has 
been incorporated into various ‘Enhanced Recovery After Surgery’ protocols.26–28 
However, intraoperative fluid restriction may cause hypoperfusion of vital organs due to 
hypovolemia. Therefore, monitoring of organ hypoperfusion during the surgery is of 
increasing importance. Because UO is usually routinely monitored in patients 
undergoing major abdominal surgery, our result suggests that intraoperative UO of <0.3 
mL kg-1 h-1 may serve as an early and easily available indicator of renal hypoperfusion 
or impending AKI. Urine flow rate of <0.3 mL kg-1 h-1 is similar to the classical 
definition of oliguria, i.e., UO of <400 mL day-1, which is determined based on the 
minimum UO required to eliminate 300 mOsm day-1 in a maximum urine concentration 
of 1,200 mOsm kg-1.29 




laparoscopic surgery. This finding is in line with previous studies that reported reduced 
diuresis during laparoscopic surgeries.30 31 Possible mechanisms include a direct 
pressure effect of pneumoperitoneum on the renal vasculature resulting in reduced renal 
blood flow and the intraoperative release of stress hormones.31 Therefore, there is a 
possibility that the threshold of clinically significant oliguria may be different between 
laparoscopic and non-laparoscopic patients. However, in our subgroup analysis, 
intraoperative UO of <0.3 mL kg-1 h-1 was significantly associated with AKI in both 
laparoscopic and non-laparoscopic patients.  
We could not find a statistically significant association between intraoperative UO of 
0.3–<0.5 mL kg-1 h-1 and AKI. Point estimate of odds ratio for intraoperative UO of 
0.3–<0.5 mL kg-1 h-1 was 1.37, which is substantially smaller than that for 
intraoperative UO of <0.3 mL kg-1 h-1. This finding suggests that the impact of 
intraoperative UO of 0.3–<0.5 mL kg-1 h-1 on AKI, if it exists, is small compared to that 
of intraoperative UO of <0.3 mL kg-1 h-1. The widely used definition of intraoperative 
oliguria (<0.5 mL kg-1 h-1) should be reconsidered because fluid replacement using a 






Strengths and limitations 
Our study has several strengths. We found that our results remained robust after 
stratifying our analysis by various patient and operative variables. This suggests that the 
relationship between intraoperative UO and AKI does not change significantly 
depending on patient characteristics or types of surgery. We also confirmed the 
robustness of our findings through extensive sensitivity analyses. We had complete data 
on independent variables and the primary outcome in 99.9% of participants. 
Our study has many limitations that should be considered when interpreting the results. 
Information on clinical risk factors of AKI were not prospectively collected; instead, 
they were retrieved from the electronic database and the electronic medical record 
system. Thus, effects of certain risk factors may have been biased. Findings of this 
observational study are merely an association and cannot imply causation; thus, we are 
unable to ascertain whether intraoperative management targeting urine flow rate at 0.3 




address this hypothesis. We could not clearly determine the duration of oliguria because 
our database contained only total UO and not hourly UO during the surgery. However, 
most patients with oliguria were assumed to have continuous reduction of UO for 3–4 h, 
considering that the duration of surgery was ≥3 h in 93.0% patients and ≥4 h in 79.5% 
patients. The single-centre design may limit the generalisability, and external validation 
is warranted to corroborate our findings. However, The incidence of AKI observed in 
our study was similar to recent large-scale studies reporting the incidence of AKI 
according to KDIGO criteria after intra-abdominal surgeries19 or non-cardiac 
surgeries.20 21 Our study included patients undergoing major abdominal surgery, so it is 
unclear whether our findings can be extrapolated to patients undergoing other surgeries. 
For example, Hori et al.32 reported an independent association between urine flow rate 
of <1.5 mL kg-1 h-1 during cardiac surgery and AKI. Further studies are required to 
determine optimal thresholds of UO in various clinical settings. 
In conclusion, among patients undergoing major abdominal surgery, intraoperative 
oliguria under 0.3 mL kg-1 h-1 was independently associated with postoperative AKI. 
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and Intraoperative UO 
  aOR (95% CI) P-Value   aOR (95% CI) P-Value 
AKI Risk Index 
     




   Class 2 2.31 (1.48–3.62) <0.001 
 
2.26 (1.44–3.54) <0.001 
   Class 3 3.82 (2.44–5.97) <0.001 
 
3.69 (2.36–5.78) <0.001 
   Class 4 5.91 (3.53–9.89) <0.001 
 
5.43 (3.23–9.12) <0.001 
   Class 5 7.39 (3.42–15.90) <0.001 
 
7.35 (3.38–16.00) <0.001 
Type of surgery 
     




   Colorectal 0.73 (0.47–1.13) 0.155 
 
0.66 (0.42–1.02) 0.062 
   Gastric 1.06 (0.66–1.69) 0.805 
 
0.87 (0.54–1.41) 0.576 
   Pancreatic 0.55 (0.37–0.83) 0.004 
 
0.57 (0.38–0.86) 0.008 
   Oesophageal 0.55 (0.23–1.31) 0.177 
 
0.58 (0.24–1.39) 0.224 
   Complex 1.17 (0.38–3.66) 0.785 
 
1.20 (0.39–3.74) 0.754 
Intraoperative blood 
loss      




   10–<20 mL kg-1 3.03 (2.00–4.59) <0.001 
 
3.22 (2.12–4.91) <0.001 
   ≥20 mL kg-1 5.58 (3.71–8.40) <0.001 
 
6.03 (3.97–9.14) <0.001 
Intraoperative 
vasopressor infusion 
1.64 (1.12–2.39) 0.010 
 
1.67 (1.15–2.44) 0.008 
Intraoperative UO 
     
   ≥0.3 mL kg-1 h-1 
   
1 (Reference) 
 
   <0.3 mL kg-1 h-1     	  2.65 (1.77–3.97) <0.001 






















































































































































































































Fig. 1 Flow diagram of the study population. We first identified adult patients undergoing a major 
abdominal surgery under general anaesthesia from those undergoing surgery in the Departments of 
Gastrointestinal Surgery, Hepatobiliary Pancreatic Surgery and Transplantation and Pediatric 
Surgery of Kyoto University Hospital using patient age, procedure name and anaesthetic technique 
as recorded in the electronic database. Then, we performed medical record review for further 






Fig. 2 Cubic spline function curves of the unadjusted relationship between intraoperative urine 
output and the probability of AKI. Shades represent 95% confidence intervals. Panel A includes a 
range of intraoperative urine output from 0 to 4 mL kg-1 h-1, and panel B includes that from 0 to 1 
















Table S1. Definitions of variables collected by questionnaire. 
Variables Definitions 
Age In years 
Gender Male or female 
Weight and height Most recent value measured before the surgery 
Hypertension History of hypertension requiring anti-hypertensive medication recorded in the 
medical chart 
Diabetes mellitus A diagnosis of diabetes requiring oral medication or insulin 
Active congestive heart 
failure 
Documented in the patient’s chart within 30 days before surgery  
A diagnosis of congestive heart failure requiring diuretics 
Ascites Documented in the patient’s chart within 30 days before surgery 
ASA-PS 1 to 5, recorded in the electronic database 




In mL min-1 1.73 m-2, calculated from preoperative SCr using a formula 
validated in Japan (Am J Kidney Dis 2009; 53: 982-92) 
AKI risk index Class 1 to 5, assigned based on age, gender, emergency surgery, 
intra-peritoneal surgery, diabetes mellitus, active congestive heart failure, 
ascites, hypertension and preoperative renal insufficiency (Anesthesiology 
2009; 110: 505–15). 
Type of surgery Grouped into six categories by operation site (colorectal, gastric, liver, 
pancreatic, oesophageal and complex) according to procedure name recorded in 
the electronic database 
Laparoscopic surgery Identified using procedure name recorded in the electronic database 
Emergency surgery An emergency procedure performed within 12 h after admission or after the 




Epidural anaesthesia Defined as an epidural catheter placement documented in the anaesthesia chart, 
regardless of duration of catheter placement 
Duration of surgery In minutes, from skin incision to skin closure 
Duration of operating 
room stay 
In minutes, from entering to leaving the operating room 
Intraoperative crystalloid 
administration 
In mL kg-1, extracted from the electronic database 
Intraoperative colloid 
administration 
In mL kg-1, extracted from the electronic database 
Intraoperative blood loss In mL kg-1, extracted from the electronic database 
Intraoperative red blood 
cell transfusion 
Administration of red blood cells during surgery 
Intraoperative UO In mL kg-1 h-1, extracted from the electronic database 
Net fluid balance during 
the surgery 
In mL kg-1, calculated by subtracting blood loss and UO from volume of fluid 
and blood products administered 
Intraoperative vasopressor 
infusion 
Use of continuous infusion of vasopressor (phenylephrine, dopamine, 
noradrenaline, adrenaline or vasopressin) during the operating room stay, 
documented in the anaesthesia chart 
AKI Defined as stage ≥1 AKI according to the Kidney Disease: Improving Global 
Outcomes guidelines  
AKI stages were assigned based on SCr change within 7 days of surgery. The 
most recent SCr measured before surgery was used as the baseline value. 
Postoperative length of 
stay 
Number of days from the surgery to discharge from the hospital 
In-hospital mortality Death during the hospital stay for the surgery 
ASA-PS, the American Society of Anaesthesiologists physical status; SCr, serum creatinine; AKI, 





Table S2. Cut-off point analysis for intraoperative UO and postoperative AKI.  
Intraoperative UO (cut-off 
points, mL kg-1 h-1) 
aOR (95% CI) P-value 
0.1 2.13 (0.69–6.64) 0.190 
0.2 3.00 (1.74–5.19) 0.00008 
0.3 2.65 (1.77–3.97) <0.00001 
0.4 2.09 (1.44–3.04) 0.00011 
0.5 1.92 (1.36–2.70) 0.00018 
0.6 2.01 (1.46–2.76) 0.00002 
0.7 1.97 (1.45–2.69) 0.00002 
0.8 2.02 (1.47–2.76) 0.00001 
0.9 1.89 (1.38–2.59) 0.00008 
1.0 1.61 (1.17–2.21) 0.00352 
Every possible threshold of intraoperative UO at intervals of 0.1 mL kg-1 h-1 was evaluated using a 
multivariable model with the AKI risk index and operative variables.  






Table S3. Patient characteristics and operative variables stratified by intraoperative UO. 
  
UO ≥0.3 mL kg-1 h-1 
(n = 3157) 
UO <0.3 mL kg-1 h-1 
(n = 403) 
P-value 
Age (years) 66 (56–73) 67 (59–75) 0.008 
Male gender 1902 (60.2%) 280 (69.5%) <0.001 
Hypertension 925 (29.3%) 153 (38.0%) 0.001 
Diabetes mellitus 509 (16.1%) 57 (14.1%) 0.347 
Active congestive heart failure 47 (1.5%) 10 (2.5%) 0.139 
Ascites 257 (8.1%) 37 (9.2%) 0.501 
ASA-PS (1/2/3/4/missing) 888/2026/207/2/34 103/271/24/1/4 0.289 
Preoperative SCr (µmol L-1) 61.9 (53.0–76.9) 70.7 (56.6–82.2) <0.001 
Preoperative estimated glomerular 
filtration rate (mL min-1 1.73 m-2) 
75.8 (64.9–88.5) 71.3 (60.3–82.1) <0.001 
AKI risk index 
   
   Class 1 1165 (36.9%) 113 (28.0%) 0.002 
   Class 2 1032 (32.7%) 142 (35.2%) 
 
   Class 3 659 (20.9%) 91 (22.6%) 
 
   Class 4 236 (7.5%) 47 (11.7%) 
 
   Class 5 65 (2.1%) 10 (2.5%) 
 
Type of surgery 
   
   Liver 1077 (34.1%) 58 (14.4%) <0.001 
   Colorectal 874 (27.7%) 180 (44.7%) 
 
   Gastric 484 (15.3%) 143 (35.5%) 
 
   Pancreatic 513 (16.2%) 12 (3.0%) 
 
   Oesophageal 181 (5.7%) 8 (2.0%) 
 
   Complex 28 (0.9%) 2 (0.5%) 
 
Laparoscopic surgery 1531 (48.5%) 329 (81.6%) <0.001 
Emergency surgery 45 (1.4%) 1 (0.2%) 0.056 
Epidural anaesthesia 1653 (52.4%) 68 (16.9%) <0.001 
Duration of surgery (min) 365 (265–480) 279 (224–348) <0.001 
Intraoperative fluid administration    
   Crystalloid (mL kg-1) 54.4 (39.3–74.4) 34.7 (26.6–44.5) <0.001 




Intraoperative blood loss  
 
<0.001 
   <10 mL kg-1 2397 (75.9%) 373 (92.6%) <0.001 
   10–<20 mL kg-1 435 (13.8%) 18 (4.5%) 
 
   ≥20 mL kg-1 325 (10.3%) 12 (3.0%) 
 
Intraoperative red blood cell 
transfusion 
285 (9.0%) 13 (3.2%) <0.001 
Intraoperative UO (mL kg-1 h-1) 0.90 (0.57–1.51) 0.23 (0.17–0.26) <0.001 
Net fluid balance during the surgery 
(mL kg-1) 
45.3 (32.6–61.8) 33.3 (25.3–42.2) <0.001 
Intraoperative vasopressor infusion 303 (9.6%) 21 (5.2%) 0.003 
Data are presented as median (interquartile range) or numbers (percentages).  
ASA-PS, the American Society of Anaesthesiologists Physical Status; SCr, serum creatinine; AKI, 






Table S4. Sensitivity analyses. Multivariable adjustment for AKI risk index and operative variables 
was performed in all analyses. 
Model 
No. of patients with 
AKI/total no. (%) 
Adjusted odds ratio of 
intraoperative oliguria (95% CI) 
P-value 
Entire sample 226/3,560 (6.3%) 2.65 (1.77–3.97) <0.001 
AKI redefined on the 
basis of SCr 
concentrations only up to 
2 days postoperatively 
197/3,560 (5.5%) 3.06 (1.98–4.71) <0.001 
Using stage 2–3 AKI as 
the outcome 
39/3,560 (1.1%) 2.86 (1.13–7.22) 0.026 
adjusting for the 
duration of surgery 
226/3,560 (6.3%) 2.74 (1.82–4.11) <0.001 
Using ideal body weight 
to calculate urine output 
per body weight* 
226/3,553 (6.4%) 2.24 (1.46–3.43) <0.001 
Excluding patients who 
received intraoperative 
vasopressor infusion 
175/3,236 (5.4%) 2.74 (1.77–4.23) <0.001 
Excluding patients who 
received diuretics 
preoperatively 
206/3407 (6.0%) 2.83 (1.84–4.34) <0.001 
Excluding emergency 
surgeries 
221/3,514 (6.3%) 2.72 (1.81–4.09) <0.001 
*Seven patients whose data on height was missing were excluded from the analysis. AKI, acute 






Fig. S1 Cubic spline analysis of the association between intraoperative blood loss and postoperative 
AKI. The test for non-linearity was statistically significant (P <0.001). The probability of AKI 
increased as a function of intraoperative blood loss until a blood loss of about 20 mL kg-1, after 
which it continued to increase with increased blood loss but at a lower rate. AKI, acute kidney 
injury. 
 
